ECRG4 and nasopharyngeal carcinoma: Furthermore, C2orf40 inhibits the resistance and migration of NPC cells to radiotherapy and chemotherapy by downregulating the expression levels of HRR-related proteins and activation of PI3K/Akt/mTOR signaling pathway.